Prognostic factors in osteosarcomas. A regression analysis
- 1 July 1988
Abstract
A multivariate regression analysis of survival data, using the Cox proportional hazards model (PHM), was performed on the retrospective material of 184 osteosarcoma patients treated at the Aarhus and Copenhagen oncology centers, Denmark, from 1963 to 1984. All patients were previously untreated. Radical surgery, in general ablative when possible, was the primary treatment goal throughout this period. A number of clinical and pathologic variables were tested in the model to elucidate their prognostic importance. Tumors localized to the trunk, pelvis, or femur, and symptom duration of less than 6 months were poor prognostic signs. Tumors dominated by fibroblastic cells and a patient age of approximately 25 to 30 years were associated with an especially good prognosis. The prognosis worsened with advancing age. Children, adolescents, and adults ages 5 to 25 years had significantly poorer prognosis than young adults 25 to 30 years of age. Sex, radiologic appearance, and year of referral had no significant prognostic value in this series. Based on the regression model, a prognostic index is derived and survival is calculated for a good and a poor prognostic case. The overall 10-year survival with one standard deviation was 28.6 ± 3.5%. Cancer deaths continue to occur 10 years after initial treatment, and the estimated hazard rate is still four times greater than that of a sex- and age-matched group of healthy individuals.This publication has 18 references indexed in Scilit:
- Trends and Variability in Survival Among Patients With Osteosarcoma: A 7-Year UpdateMayo Clinic Proceedings, 1985
- Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapyCancer, 1982
- Evaluation of results of new treatments for osteosarcomaInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Can historical controls be used in current clinical trials in osteosarcoma? Metastases and survival in a historical and a concurrent groupInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Adjuvant chemotherapy in nonmetastatic osteosarcoma: A southwest oncology group studyMedical and Pediatric Oncology, 1980
- Osteosarcoma of bone and its important recognizable varietiesThe American Journal of Surgical Pathology, 1977
- Prognostic factors in osteosarcoma: A review of 20 years' experience at the university of pittsburgh health center hospitalsCancer, 1975
- Adjuvant Methotrexate and Citrovorum-Factor Treatment of Osteogenic SarcomaNew England Journal of Medicine, 1974
- 10 Prognosis in Osteogenic SarcomaPublished by Wolters Kluwer Health ,1968
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958